- Topotecan2008 | Publication without faculty affiliation
- Topotecan in Pediatric Patients with Poor Prognosis Solid Tumors1999 | Central Library of Charles University
- Therapy of small cell lung cancer with emphasis on oral topotecan2010 | Central Library of Charles University
- The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant2022 | Second Faculty of Medicine, First Faculty of Medicine
- Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model2021 | Second Faculty of Medicine
- Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment2023 | Second Faculty of Medicine, Faculty of Science
- Influence of cytostatic agents on ovarian cancer cells obtained from tumor and ascites +12009 | Faculty of Medicine in Hradec Králové
- Influence of cytostatic agents on ovarian cancer cells obtained from tumor and ascites2009 | First Faculty of Medicine
- Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: Alternative retinoblastoma treatment2012 | Second Faculty of Medicine
- 2-Hydroxyethyl Methacrylate Hydrogels for Local Drug Delivery: Study of Topotecan and Vincristine Sorption/Desorption Kinetics and Polymer-Drug Interaction by ATR-FTIR Spectroscopy2021 | Second Faculty of Medicine
- Therapy of small cell lung cancer with emphasis on oral topotecan2010 | Faculty of Medicine in Pilsen
- Monitoring of etoposid and topotecan levels by HPLC after periocular and intravitreal aplication in retinoblastoma therapy2012 | Second Faculty of Medicine
- Antiproliferative effects of selected chemotherapeutics in human ovarian cancer cell line A27802012 | Faculty of Medicine in Hradec Králové
- Hydrogel implants for transscleral drug delivery for retinoblastoma treatment2019 | Second Faculty of Medicine
- Use of cryopreserved ovarian cancer cells to chemosensitivity testing2010 | Faculty of Medicine in Hradec Králové
- Bevacizumab in the treatment of uterine cervix carcinoma2020 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Resistance/sensitivity in vitro in ovarian cancer patients2010 | Faculty of Medicine in Hradec Králové
- Chemoresistance/chemosensitivity in vitro in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Chemoresistance testing of human ovarian cancer cells and its in vitro model2010 | Faculty of Medicine in Hradec Králové
- Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro2015 | Faculty of Pharmacy in Hradec Králové
- Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial2020 | First Faculty of Medicine
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial2017 | Second Faculty of Medicine